Senior insider sale
Chief Executive Officer at MINERALYS THERAPEUTICS, INC. — senior position signals high conviction
$2.67M
101.43K shares
What this filing means
CONGLETON JON plans to sell 101.43K shares of MINERALYS THERAPEUTICS, INC. valued at approximately $2.67M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/13/2026ACC: 0001964306-26-000316
DirectorOfficer· Chief Executive Officer
Since Feb 2026
101.43K
Shares to sell
$2.67M
Approx. market value
10.70K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Unit Awards
Granted as part of issuer equity compensation plan
7/10/2026
10.70KTotal acquired10.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/10/2026 | Vesting of Restricted Stock Unit Awards Granted as part of issuer equity compensation plan | 10.70K | — |
| Total | 10.70K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
75K
Market value
$1.96M
6/30/2026
—Completed
Units to sell
15.73K
Market value
$422.0K
4/13/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
10.70K
Market value
$291.4K
7/13/2026
Total
Units
101.43K
Value
$2.67M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/30/2026 | 75K | $1.96M | — | Completed |
4/13/2026 | 15.73K | $422.0K | — | Completed |
| Planned — Approximate Date | ||||
7/13/2026 | 10.70K | $291.4K | Nasdaq | Planned |
| Total | 101.43K | $2.67M | ||